WordNet

a disorder of lipid metabolism; abnormal levels of certain fats accumulate in the body

English Journal

Genetic risk assessment for cardiovascular disease in Azoreans (Portugal): a general population-based study.

Correia M, Branco CC, Bruffaerts N, Balagué A, Mota-Vieira L.SourceMolecular Genetics and Pathology Unit, Hospital of Divino Espirito Santo of Ponta Delgada, EPE, São Miguel Island, Azores, Portugal.
Gene.Gene.2013 Dec 10;532(1):132-9. doi: 10.1016/j.gene.2013.08.099. Epub 2013 Sep 13.
The identification of clinically validated genetic variants contributing to complex disorders raise the possibility to investigate individuals' risk. In this line of research, the present work aimed to assess the genetic risk for cardiovascular disease (CVD) in Azoreans. Genotyping of 19 SNPs - 9 on
PMID 24042129

Radial augmentation index is a surrogate marker of atherosclerotic burden in a primary prevention cohort.

Rosenbaum D, Giral P, Chapman J, Rached FH, Kahn JF, Bruckert E, Girerd X.SourceUnité de Prévention Cardiovasculaire, Service d'Endocrinologie-Métabolisme, Assistance Publique/Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France; Dyslipoproteinemia and Atherosclerosis Research Unit, UMRS 939, National Institute for Health and Medical Research (INSERM) and Pierre et Marie Curie University (UPMC - Paris VI), Paris, France. Electronic address: David.rosenbaum@psl.aphp.fr.
Atherosclerosis.Atherosclerosis.2013 Dec;231(2):436-41. doi: 10.1016/j.atherosclerosis.2013.10.004. Epub 2013 Oct 12.
Arterial stiffness is linked to cardiovascular risk and predicts clinical events independently of peripheral blood pressure. The potential relationship between the augmentation index measured at the radial artery and asymptomatic atherosclerosis remains unclear however. In order to assess relationsh
PMID 24267263

New Therapies Targeting apoB Metabolism for High-Risk Patients with Inherited Dyslipidaemias: What Can the Clinician Expect?

Sahebkar A, Watts GF.SourceBiotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy.Cardiovasc Drugs Ther.2013 Dec;27(6):559-67. doi: 10.1007/s10557-013-6479-4.
Apolipoprotein B (apoB) has a key role in the assembly and secretion of very low-density lipoprotein (VLDL) from the liver. Plasma apoB concentration affects the number of circulating atherogenic particles, and serves as an independent predictor of the risk of atherosclerotic cardiovascular disease.
PMID 23913122

PJ-389 Nuclear Magnetic Resonance Spectroscopy Reveals Atherogenic Dyslipoproteinemia in the Metabolic Syndrome(Lipid Disorders 2 (IHD) : PJ65)(Poster Session (Japanese))

Miyazaki Tetsuro,Shimada Kazunori,Kume Atsumi,Sumiyoshi Katsuhiko,Sato Yayoi,Watanabe Yoshiro,Mokuno Hiroshi,Daida Hiroyuki
Circulation journal : official journal of the Japanese Circulation Society 68(Supplement_I), 575, 2004-03-01
NAID 110002701995